Disc Medicine Inc
IRONHealthcare|Biotechnology|USA
$76.59
-2.32 (-2.94%)
Tangible Book
$18.03
Earnings Power
$18.04
Upcoming Data Readouts (5)
Sep 2026
Est. completion
P3Erythropoietic Protoporphyria (EPP)
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
NCT06910358n=183
Sep 2026
Est. completion
P1P2Myelofibrosis; Anemia
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
NCT05320198n=150
Oct 2026
Est. completion
P2Inflammatory Bowel Disease (IBD)
Study of DISC-0974-201 in Participants With IBD and Anemia
NCT07368972n=21
Feb 2027
Est. completion
P2Polycythemia Vera (PV)
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147n=60
Jun 2027
Est. completion
P1Sickle Cell Disease
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
NCT07187973n=24